Generation of integration-free induced pluripotent stem cell (iPSC) line MURAi002-A from hemoglobin E/β-thalassemia disease patient harboring βE/β0 (CD41/42, –CTTT) compound heterozygous mutation
| dc.contributor.author | Pornratananont G. | |
| dc.contributor.author | Tangprasittipap A. | |
| dc.contributor.author | Wongborisuth C. | |
| dc.contributor.author | Chumchuen S. | |
| dc.contributor.author | Bhukhai K. | |
| dc.contributor.author | Anurathapan U. | |
| dc.contributor.author | Hongeng S. | |
| dc.contributor.author | Songdej D. | |
| dc.contributor.correspondence | Pornratananont G. | |
| dc.contributor.other | Mahidol University | |
| dc.date.accessioned | 2025-06-07T18:21:28Z | |
| dc.date.available | 2025-06-07T18:21:28Z | |
| dc.date.issued | 2025-08-01 | |
| dc.description.abstract | The HBB gene encodes the β-globin protein, a component of adult hemoglobin A (HbA) which is responsible for the transportation of oxygen. Mutations in the HBB gene can impair β-globin synthesis and disrupt hemoglobin production. Patients who possess both a protein-reducing β-thalassemia mutation and a β<sup>E</sup> mutation in their HBB gene are affected by hemoglobin E/β-thalassemia disease. This study demonstrates the successful generation and characterization of the human pluripotent stem cell (hiPSC) line MURAi002-A derived from a patient with hemoglobin E/β<sup>0</sup>-thalassemia disease harboring the specific codon 41/42 (−CTTT) β<sup>0</sup>-thalassemia mutation through the utilization of non-integrative reprogramming episomes. | |
| dc.identifier.citation | Stem Cell Research Vol.86 (2025) | |
| dc.identifier.doi | 10.1016/j.scr.2025.103743 | |
| dc.identifier.eissn | 18767753 | |
| dc.identifier.issn | 18735061 | |
| dc.identifier.scopus | 2-s2.0-105006762899 | |
| dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/110567 | |
| dc.rights.holder | SCOPUS | |
| dc.subject | Biochemistry, Genetics and Molecular Biology | |
| dc.title | Generation of integration-free induced pluripotent stem cell (iPSC) line MURAi002-A from hemoglobin E/β-thalassemia disease patient harboring βE/β0 (CD41/42, –CTTT) compound heterozygous mutation | |
| dc.type | Article | |
| mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105006762899&origin=inward | |
| oaire.citation.title | Stem Cell Research | |
| oaire.citation.volume | 86 | |
| oairecerif.author.affiliation | Faculty of Medicine Ramathibodi Hospital, Mahidol University | |
| oairecerif.author.affiliation | Faculty of Science, Mahidol University |
